The Road to MYCAPSSA: A Conversation with Dr. Bill Ludlam

We recently had a chance to sit down with Chiasma Inc.’s Senior VP of Clinical Development & Medical Affairs, Dr. Bill Ludlam, to discuss...

Follow ups: Why are they so critical?

Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.


Interesting inquiries prompted by the questions patients leave in their health portals.

A pituitary patient’s experience with COVID-19

A compelling, detailed account of a pituitary patient's experience with COVID-19 everyone should listen.  As the virus takes hold in what is undoubtedly the...

Telemedicine and COVID-19, insights from our survey

Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients' access to healthcare.  Our brief survey elicited information from respondents on their experiences and...

A talk with Crinetics Chairman Scott Struthers, Ph.D.

During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder...

The things to take into consideration in interpreting pituitary lab results

In this eye-opening podcast, Dr. Lewis Blevins takes an in-depth look at the science of interpreting pituitary lab results and shares some of the...

A tale of two patients: the biology of different pituitary tumors

Two patients with residual pituitary tumors and their unpredictable differences.

Telemedicine: adapting to change

Telemedicine, how practices have adapted, views on pros and cons, and how things may change in the future.

What is the World Alliance of Pituitary Organizations?

With the upcoming WAPO Summit slated for this October 3, we thought we'd give our audience around the world more information about the Summit...